Treating Individuals With Eating Disorders: Part 2
Abstract
Health care providers often need additional training to understand the recommended treatment for eating disorders (EDs). Treatment varies by diagnosis and particularly for vulnerable populations (e.g., adolescents, pregnant women). EDs have life-threatening consequences and require timely interventions. Treatment tends to focus on decreasing disordered eating behaviors, psychological suffering, and nutritional deficits associated with EDs while simultaneously promoting whole health. An overview of EDs was presented in the first article of this two-part series about treating EDs. The current article discusses pharmacological and nonpharmacological evidence-based treatments for EDs. [Journal of Psychosocial Nursing and Mental Health Services, 58(4), 9-15.].
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.